chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate, Hypokinesia, Myalgia, Pain in extremity
Clinical narrative: she can not move her right leg at all where she had the cancer, it is in so much pain; she can not move her right leg at all where she had the cancer; right arm injection site pain; reports that she had could not breathe and had shortness of breath; about 3-4 hours post vaccination, all of her muscles were really sore/she had a lot of muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (reports that she had could not breathe and had shortness of breath), PAIN IN EXTREMITY (she can not move her right leg at all where she had the cancer, it is in so much pain), HYPOKINESIA (she can not move her right leg at all where she had the cancer), MYALGIA (about 3-4 hours post vaccination, all of her muscles were really sore/she had a lot of muscle pain) and VACCINATION SITE PAIN (right arm injection site pain) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Chemotherapy. Concurrent medical conditions included Leukemia (had blood cancer in the left arm) and Sarcoma (had sarcoma in the right leg and had chemotherapy and radiation (this cancer attacked her entire right femur and she had to get an incision from the groin all the way down to the knee)). Concomitant products included VITAMINS NOS, PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]), ZOLPIDEM TARTRATE (AMBIEN) and ALPRAZOLAM (XANAX) for an unknown indication.   On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-May-2021, the patient experienced DYSPNOEA (reports that she had could not breathe and had shortness of breath) and MYALGIA (about 3-4 hours post vaccination, all of her muscles were really sore/she had a lot of muscle pain). On 01-Jun-2021, the patient experienced PAIN IN EXTREMITY (she can not move her right leg at all where she had the cancer, it is in so much pain), HYPOKINESIA (she can not move her right leg at all where she had the cancer) and VACCINATION SITE PAIN (right arm injection site pain). At the time of the report, DYSPNOEA (reports that she had could not breathe and had shortness of breath), PAIN IN EXTREMITY (she can not move her right leg at all where she had the cancer, it is in so much pain), HYPOKINESIA (she can not move her right leg at all where she had the cancer), MYALGIA (about 3-4 hours post vaccination, all of her muscles were really sore/she had a lot of muscle pain) and VACCINATION SITE PAIN (right arm injection site pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-May-2021, Heart rate: 120 heart beats per minute (High) 120 bpm (as per patient high for her age).         No treatment information was provided.   This case was linked to MOD-2021-193250 (Patient Link).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: she can not move her right leg at all where she had the cancer, it is in so much pain; she can not move her right leg at all where she had the cancer; right arm injection site pain; reports that she had could not breathe and had shortness of breath; about 3-4 hours post vaccination, all of her muscles were really sore/she had a lot of muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (reports that she had could not breathe and had shortness of breath), PAIN IN EXTREMITY (she can not move her right leg at all where she had the cancer, it is in so much pain), HYPOKINESIA (she can not move her right leg at all where she had the cancer), MYALGIA (about 3-4 hours post vaccination, all of her muscles were really sore/she had a lot of muscle pain) and VACCINATION SITE PAIN (right arm injection site pain) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Chemotherapy. Concurrent medical conditions included Leukemia (had blood cancer in the left arm) and Sarcoma (had sarcoma in the right leg and had chemotherapy and radiation (this cancer attacked her entire right femur and she had to get an incision from the groin all the way down to the knee)). Concomitant products included VITAMINS NOS, PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]), ZOLPIDEM TARTRATE (AMBIEN) and ALPRAZOLAM (XANAX) for an unknown indication.   On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-May-2021, the patient experienced DYSPNOEA (reports that she had could not breathe and had shortness of breath) and MYALGIA (about 3-4 hours post vaccination, all of her muscles were really sore/she had a lot of muscle pain). On 01-Jun-2021, the patient experienced PAIN IN EXTREMITY (she can not move her right leg at all where she had the cancer, it is in so much pain), HYPOKINESIA (she can not move her right leg at all where she had the cancer) and VACCINATION SITE PAIN (right arm injection site pain). At the time of the report, DYSPNOEA (reports that she had could not breathe and had shortness of breath), PAIN IN EXTREMITY (she can not move her right leg at all where she had the cancer, it is in so much pain), HYPOKINESIA (she can not move her right leg at all where she had the cancer), MYALGIA (about 3-4 hours post vaccination, all of her muscles were really sore/she had a lot of muscle pain) and VACCINATION SITE PAIN (right arm injection site pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-May-2021, Heart rate: 120 heart beats per minute (High) 120 bpm (as per patient high for her age).         No treatment information was provided.   This case was linked to MOD-2021-193250 (Patient Link).
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pyrexia
Clinical narrative: Felt like I had a cold; Felt like I had a fever; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Felt like I had a cold) and PYREXIA (Felt like I had a fever) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     The medical history was not provided by the reporter.  Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC), BUSPIRONE HYDROCHLORIDE (BUSPAR) and LAMOTRIGINE (LAMICTAL) for an unknown indication.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced NASOPHARYNGITIS (Felt like I had a cold) and PYREXIA (Felt like I had a fever). At the time of the report, NASOPHARYNGITIS (Felt like I had a cold) and PYREXIA (Felt like I had a fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The treatment information was reported as some unknown medication for cold.   This case was linked to MOD-2021-240827 (Patient Link).
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during breast feeding, Myalgia, Pain in extremity
Clinical narrative: Breastfeeding; Sore arm; Muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), MYALGIA (Muscle ache) and MATERNAL EXPOSURE DURING BREAST FEEDING (Breastfeeding) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014C21A and 025B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO), MAGNESIUM, VITAMIN D3 and ACETYLSALICYLIC ACID (ASPIRIN LOW) for an unknown indication.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-May-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and MYALGIA (Muscle ache). On an unknown date, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (Breastfeeding). At the time of the report, PAIN IN EXTREMITY (Sore arm) and MYALGIA (Muscle ache) outcome was unknown and MATERNAL EXPOSURE DURING BREAST FEEDING (Breastfeeding) had resolved.            No treatment information was provided.   This case was linked to MOD-2021-068370 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia
Clinical narrative: tired; aches and pain; This spontaneous pregnancy case was reported by a consumer and describes the occurrence of FATIGUE (tired) and MYALGIA (aches and pain) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included High cholesterol. Concomitant products included ATORVASTATIN for High cholesterol.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 26-Feb-2021, the patient experienced FATIGUE (tired) and MYALGIA (aches and pain). On 27-Feb-2021, FATIGUE (tired) and MYALGIA (aches and pain) had resolved. Not Provided          No treatment medications was  provided by the reporter. No concomitant medications was reported by the reporter. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-019237 (Patient Link).   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient here for his second dose, however it's been 6.5 weeks since his first dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient here for his second dose, however it's been 6.5 weeks since his first dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jun-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient here for his second dose, however it's been 6.5 weeks since his first dose). On 29-Jun-2021, PRODUCT DOSE OMISSION ISSUE (Patient here for his second dose, however it's been 6.5 weeks since his first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Fluid retention, Inappropriate schedule of product administration, Swelling
Clinical narrative: the patient had fluid retention  all over her body; body was swelling; Received second dose 43 days after first dose; This spontaneous case was reported by a consumer and describes the occurrence of FLUID RETENTION (the patient had fluid retention  all over her body), SWELLING (body was swelling) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second dose 43 days after first dose) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039B21A and 039B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FLUID RETENTION (the patient had fluid retention  all over her body), SWELLING (body was swelling) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second dose 43 days after first dose). The patient was treated with FUROSEMIDE at an unspecified dose and frequency and NITROFURANTOIN at an unspecified dose and frequency. At the time of the report, FLUID RETENTION (the patient had fluid retention  all over her body), SWELLING (body was swelling) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second dose 43 days after first dose) outcome was unknown.            No concomitant medications were not reported.
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: head hurts a lot; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (head hurts a lot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (head hurts a lot). At the time of the report, HEADACHE (head hurts a lot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not reported.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Received 1st dose 28Apr2021 has not received 2nd dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Received 1st dose 28Apr2021 has not received 2nd dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Received 1st dose 28Apr2021 has not received 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Received 1st dose 28Apr2021 has not received 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment information was not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Received 1st dose 29Apr2021 has not received 2nd dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Received 1st dose 29Apr2021 has not received 2nd dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Received 1st dose 29Apr2021 has not received 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Received 1st dose 29Apr2021 has not received 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The pharmacist isnot aware of any side effects due to the missed second vaccine dose.  No concomitant medications information was provided No treatment information were provided
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect route of product administration, Myalgia
Clinical narrative: 2nd COVID vaccine injection hit my bursa/ She suspect that it was given in her non deltoid muscle in the left arm; Arm pain/ having pain in arm for 2 months post the second shot/ had pretty severe reactions/ pain in arm feels as got punched in the arm still; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (2nd COVID vaccine injection hit my bursa/ She suspect that it was given in her non deltoid muscle in the left arm) and MYALGIA (Arm pain/ having pain in arm for 2 months post the second shot/ had pretty severe reactions/ pain in arm feels as got punched in the arm still) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Unknown and 001C21A)) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (2nd COVID vaccine injection hit my bursa/ She suspect that it was given in her non deltoid muscle in the left arm) and MYALGIA (Arm pain/ having pain in arm for 2 months post the second shot/ had pretty severe reactions/ pain in arm feels as got punched in the arm still). At the time of the report, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (2nd COVID vaccine injection hit my bursa/ She suspect that it was given in her non deltoid muscle in the left arm) and MYALGIA (Arm pain/ having pain in arm for 2 months post the second shot/ had pretty severe reactions/ pain in arm feels as got punched in the arm still) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Action taken with mRNA-1273 in response to the events was not applicable  No concomitant medications was provided by the reporter. No treatment medications was provided by the reporter   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Follow up received on 29-jun-2021 patient details city postcode  and age sex were added
Sex: U
Vaccine: COVID19
Symptoms: Inflammation, Pruritus, Rash erythematous, Swelling
Clinical narrative: I have a rash that is red an inflamed with bumps an some swelling and itches horribly; an inflamed with bumps an some swelling; itches horribly; inflammed; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (I have a rash that is red an inflamed with bumps an some swelling and itches horribly), SWELLING (an inflamed with bumps an some swelling), PRURITUS (itches horribly) and INFLAMMATION (inflammed) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 16-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-May-2021, the patient experienced RASH ERYTHEMATOUS (I have a rash that is red an inflamed with bumps an some swelling and itches horribly). On an unknown date, the patient experienced SWELLING (an inflamed with bumps an some swelling), PRURITUS (itches horribly) and INFLAMMATION (inflammed). At the time of the report, RASH ERYTHEMATOUS (I have a rash that is red an inflamed with bumps an some swelling and itches horribly) outcome was unknown.            No concomitant medication was provided.  No Treatment medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Getting a tingling sensation in the vagina after vaccination shots; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Getting a tingling sensation in the vagina after vaccination shots) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Getting a tingling sensation in the vagina after vaccination shots). At the time of the report, PARAESTHESIA (Getting a tingling sensation in the vagina after vaccination shots) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided. Concomitant product use was not provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Swollen tongue
Clinical narrative: This spontaneous case reported by a nurse, describes the occurrence of swollen tongue and rash in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 010M20A) for COVID-19 immunization. No medical history reported. On Feb 1, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Feb 2, 2021, patient had a swollen tongue and rash. Patient treated with 12.5mg liquid Benadryl (diphenhydramine hydrochloride), at an unspecified dose and frequency. On Feb 3, 2021, swollen tongue and rash resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The reporter did not provide any causality assessments or concomitant medication.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: inappropriate schedule of vaccine administered; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039C21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) and CLOPIDOGREL BISULFATE (PLAVIX) for Acute myocardial infarction, ASPIRIN [ACETYLSALICYLIC ACID] for Myocardial infarction acute.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jun-2021 at 12:05 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered). On 15-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-163703 (Patient Link).
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Bedridden, Bone pain, Cardiac disorder, Chest pain, Dizziness
Clinical narrative: then his heart hurt/ very slowly as when breathing normally his heart hurt; couldnt breathe at 100%/had to breathe at 50% like the hens; He stated that if he breathed strong, when his lungs are inflated, his heart hurt; headache; felt very painful/ his arm hurt , his body, his soul, his spirit hurt; Heart was inflamed; bone pain; felt dizzy; was in bed for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC DISORDER (Heart was inflamed), BONE PAIN (bone pain), DIZZINESS (felt dizzy), BEDRIDDEN (was in bed for 3 days) and CHEST PAIN (then his heart hurt/ very slowly as when breathing normally his heart hurt) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes and Blood pressure.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, the patient experienced CARDIAC DISORDER (Heart was inflamed), BONE PAIN (bone pain), DIZZINESS (felt dizzy), BEDRIDDEN (was in bed for 3 days), HEADACHE (headache) and MYALGIA (felt very painful/ his arm hurt , his body, his soul, his spirit hurt). On an unknown date, the patient experienced CHEST PAIN (then his heart hurt/ very slowly as when breathing normally his heart hurt), DYSPNOEA (couldnt breathe at 100%/had to breathe at 50% like the hens) and PNEUMONITIS (He stated that if he breathed strong, when his lungs are inflated, his heart hurt). On 29-May-2021, CARDIAC DISORDER (Heart was inflamed), BONE PAIN (bone pain), DIZZINESS (felt dizzy) and BEDRIDDEN (was in bed for 3 days) had resolved, HEADACHE (headache) and MYALGIA (felt very painful/ his arm hurt , his body, his soul, his spirit hurt) outcome was unknown. At the time of the report, CHEST PAIN (then his heart hurt/ very slowly as when breathing normally his heart hurt), DYSPNOEA (couldnt breathe at 100%/had to breathe at 50% like the hens) and PNEUMONITIS (He stated that if he breathed strong, when his lungs are inflated, his heart hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Medication includes for back pain, blood pressure and blood pressure no treatment details reported.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Myalgia, Pneumonitis
Clinical narrative: then his heart hurt/ very slowly as when breathing normally his heart hurt; couldnt breathe at 100%/had to breathe at 50% like the hens; He stated that if he breathed strong, when his lungs are inflated, his heart hurt; headache; felt very painful/ his arm hurt , his body, his soul, his spirit hurt; Heart was inflamed; bone pain; felt dizzy; was in bed for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC DISORDER (Heart was inflamed), BONE PAIN (bone pain), DIZZINESS (felt dizzy), BEDRIDDEN (was in bed for 3 days) and CHEST PAIN (then his heart hurt/ very slowly as when breathing normally his heart hurt) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes and Blood pressure.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, the patient experienced CARDIAC DISORDER (Heart was inflamed), BONE PAIN (bone pain), DIZZINESS (felt dizzy), BEDRIDDEN (was in bed for 3 days), HEADACHE (headache) and MYALGIA (felt very painful/ his arm hurt , his body, his soul, his spirit hurt). On an unknown date, the patient experienced CHEST PAIN (then his heart hurt/ very slowly as when breathing normally his heart hurt), DYSPNOEA (couldnt breathe at 100%/had to breathe at 50% like the hens) and PNEUMONITIS (He stated that if he breathed strong, when his lungs are inflated, his heart hurt). On 29-May-2021, CARDIAC DISORDER (Heart was inflamed), BONE PAIN (bone pain), DIZZINESS (felt dizzy) and BEDRIDDEN (was in bed for 3 days) had resolved, HEADACHE (headache) and MYALGIA (felt very painful/ his arm hurt , his body, his soul, his spirit hurt) outcome was unknown. At the time of the report, CHEST PAIN (then his heart hurt/ very slowly as when breathing normally his heart hurt), DYSPNOEA (couldnt breathe at 100%/had to breathe at 50% like the hens) and PNEUMONITIS (He stated that if he breathed strong, when his lungs are inflated, his heart hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Medication includes for back pain, blood pressure and blood pressure no treatment details reported.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: did not yet get her second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (did not yet get her second dose) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jun-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (did not yet get her second dose). On 29-Jun-2021, PRODUCT DOSE OMISSION ISSUE (did not yet get her second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: IST DOSE WAS GIVEN ON 04/28. SHE WANTED SECOND DOSE ON 06/29.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (IST DOSE WAS GIVEN ON 04/28. SHE WANTED SECOND DOSE ON 06/29.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (IST DOSE WAS GIVEN ON 04/28. SHE WANTED SECOND DOSE ON 06/29.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (IST DOSE WAS GIVEN ON 04/28. SHE WANTED SECOND DOSE ON 06/29.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drug was not reported. Treatment medication was not reported.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Erythema, Feeling hot, Flushing, Hypoaesthesia
Clinical narrative: redness of eyes; redness of body and my hand; Stiffness of neck; flushing; Tingling; chills; Thickening of skin; feeling hot; Numbness in hand; Pain; Rashes; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), OCULAR HYPERAEMIA (redness of eyes), ERYTHEMA (redness of body and my hand), HYPOAESTHESIA (Numbness in hand) and MUSCULOSKELETAL STIFFNESS (Stiffness of neck) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Chemical sensitivity (Allergic to Quinines.).    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN (Pain) and RASH (Rashes). On 23-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness in hand), SKIN HYPERTROPHY (Thickening of skin), FEELING HOT (feeling hot) and CHILLS (chills). On an unknown date, the patient experienced OCULAR HYPERAEMIA (redness of eyes), ERYTHEMA (redness of body and my hand), MUSCULOSKELETAL STIFFNESS (Stiffness of neck), FLUSHING (flushing) and PARAESTHESIA (Tingling). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at an unspecified dose and frequency. At the time of the report, PAIN (Pain) and RASH (Rashes) had resolved and OCULAR HYPERAEMIA (redness of eyes), ERYTHEMA (redness of body and my hand), HYPOAESTHESIA (Numbness in hand), MUSCULOSKELETAL STIFFNESS (Stiffness of neck), SKIN HYPERTROPHY (Thickening of skin), FEELING HOT (feeling hot), FLUSHING (flushing), PARAESTHESIA (Tingling) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No information on concomitant medications reported. The patient reported "medicines" used for pain and rashes following first dose as a corrective treatment   This case was linked to MOD-2021-241151 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Significant follow up appended. patient demographics added. Allergy to Quinines added. Events: Red/itchy eyes, chills, prickling/tingling sensation,Numbness,feeling hot, flushing. Added. Events outcome is unknown. Benadryl was added as treatment for rashes
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Ocular hyperaemia, Pain, Paraesthesia, Rash
Clinical narrative: redness of eyes; redness of body and my hand; Stiffness of neck; flushing; Tingling; chills; Thickening of skin; feeling hot; Numbness in hand; Pain; Rashes; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), OCULAR HYPERAEMIA (redness of eyes), ERYTHEMA (redness of body and my hand), HYPOAESTHESIA (Numbness in hand) and MUSCULOSKELETAL STIFFNESS (Stiffness of neck) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Chemical sensitivity (Allergic to Quinines.).    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN (Pain) and RASH (Rashes). On 23-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness in hand), SKIN HYPERTROPHY (Thickening of skin), FEELING HOT (feeling hot) and CHILLS (chills). On an unknown date, the patient experienced OCULAR HYPERAEMIA (redness of eyes), ERYTHEMA (redness of body and my hand), MUSCULOSKELETAL STIFFNESS (Stiffness of neck), FLUSHING (flushing) and PARAESTHESIA (Tingling). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at an unspecified dose and frequency. At the time of the report, PAIN (Pain) and RASH (Rashes) had resolved and OCULAR HYPERAEMIA (redness of eyes), ERYTHEMA (redness of body and my hand), HYPOAESTHESIA (Numbness in hand), MUSCULOSKELETAL STIFFNESS (Stiffness of neck), SKIN HYPERTROPHY (Thickening of skin), FEELING HOT (feeling hot), FLUSHING (flushing), PARAESTHESIA (Tingling) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No information on concomitant medications reported. The patient reported "medicines" used for pain and rashes following first dose as a corrective treatment   This case was linked to MOD-2021-241151 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Significant follow up appended. patient demographics added. Allergy to Quinines added. Events: Red/itchy eyes, chills, prickling/tingling sensation,Numbness,feeling hot, flushing. Added. Events outcome is unknown. Benadryl was added as treatment for rashes
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Skin hypertrophy
Clinical narrative: redness of eyes; redness of body and my hand; Stiffness of neck; flushing; Tingling; chills; Thickening of skin; feeling hot; Numbness in hand; Pain; Rashes; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), OCULAR HYPERAEMIA (redness of eyes), ERYTHEMA (redness of body and my hand), HYPOAESTHESIA (Numbness in hand) and MUSCULOSKELETAL STIFFNESS (Stiffness of neck) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Chemical sensitivity (Allergic to Quinines.).    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN (Pain) and RASH (Rashes). On 23-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness in hand), SKIN HYPERTROPHY (Thickening of skin), FEELING HOT (feeling hot) and CHILLS (chills). On an unknown date, the patient experienced OCULAR HYPERAEMIA (redness of eyes), ERYTHEMA (redness of body and my hand), MUSCULOSKELETAL STIFFNESS (Stiffness of neck), FLUSHING (flushing) and PARAESTHESIA (Tingling). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at an unspecified dose and frequency. At the time of the report, PAIN (Pain) and RASH (Rashes) had resolved and OCULAR HYPERAEMIA (redness of eyes), ERYTHEMA (redness of body and my hand), HYPOAESTHESIA (Numbness in hand), MUSCULOSKELETAL STIFFNESS (Stiffness of neck), SKIN HYPERTROPHY (Thickening of skin), FEELING HOT (feeling hot), FLUSHING (flushing), PARAESTHESIA (Tingling) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No information on concomitant medications reported. The patient reported "medicines" used for pain and rashes following first dose as a corrective treatment   This case was linked to MOD-2021-241151 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Significant follow up appended. patient demographics added. Allergy to Quinines added. Events: Red/itchy eyes, chills, prickling/tingling sensation,Numbness,feeling hot, flushing. Added. Events outcome is unknown. Benadryl was added as treatment for rashes
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: injection site is hot; injection site is swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (injection site is hot) and VACCINATION SITE SWELLING (injection site is swollen) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (injection site is hot) and VACCINATION SITE SWELLING (injection site is swollen). At the time of the report, VACCINATION SITE WARMTH (injection site is hot) and VACCINATION SITE SWELLING (injection site is swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment details were reported.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Eye pruritus, Feeling hot, Flushing, Hypoaesthesia
Clinical narrative: Numbness in whole hand and fingers; tingling in finger; Pain in neck; neck stiffness/neck spasm; flushing; feeling hot; itchy eyes; Rashness and thicknening of the skin; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in whole hand and fingers), PARAESTHESIA (tingling in finger), NECK PAIN (Pain in neck), MUSCULOSKELETAL STIFFNESS (neck stiffness/neck spasm) and FLUSHING (flushing) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022B2117 and 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Patient allergic to quinines.).   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness in whole hand and fingers), PARAESTHESIA (tingling in finger), NECK PAIN (Pain in neck), MUSCULOSKELETAL STIFFNESS (neck stiffness/neck spasm), FLUSHING (flushing), FEELING HOT (feeling hot), EYE PRURITUS (itchy eyes), RASH (Rashness and thicknening of the skin) and CHILLS (chills). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (Numbness in whole hand and fingers), PARAESTHESIA (tingling in finger), NECK PAIN (Pain in neck), FLUSHING (flushing), FEELING HOT (feeling hot), EYE PRURITUS (itchy eyes), RASH (Rashness and thicknening of the skin) and CHILLS (chills) outcome was unknown and MUSCULOSKELETAL STIFFNESS (neck stiffness/neck spasm) had not resolved.            No concomitant medications were provided by the reporter.  It was reported that after 2 and half to 3 months later (may-2021) patient started noticing numbeness of right hand, twingling of fingers and stiffness of neck especially while sleeping, un esay when hand is in rest, unable to see the mirror.  This case was linked to MOD-2021-241131 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Added patient height & weight,,batch/ lot number of the first dose, allergic condition, updated the vaccine facility information, treatment for neck spasm,updated symptoms include chills, flushing, feeling hot, rash & the event out come for neck spasm as ongoing.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Neck pain, Paraesthesia, Rash
Clinical narrative: Numbness in whole hand and fingers; tingling in finger; Pain in neck; neck stiffness/neck spasm; flushing; feeling hot; itchy eyes; Rashness and thicknening of the skin; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in whole hand and fingers), PARAESTHESIA (tingling in finger), NECK PAIN (Pain in neck), MUSCULOSKELETAL STIFFNESS (neck stiffness/neck spasm) and FLUSHING (flushing) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022B2117 and 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Patient allergic to quinines.).   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness in whole hand and fingers), PARAESTHESIA (tingling in finger), NECK PAIN (Pain in neck), MUSCULOSKELETAL STIFFNESS (neck stiffness/neck spasm), FLUSHING (flushing), FEELING HOT (feeling hot), EYE PRURITUS (itchy eyes), RASH (Rashness and thicknening of the skin) and CHILLS (chills). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (Numbness in whole hand and fingers), PARAESTHESIA (tingling in finger), NECK PAIN (Pain in neck), FLUSHING (flushing), FEELING HOT (feeling hot), EYE PRURITUS (itchy eyes), RASH (Rashness and thicknening of the skin) and CHILLS (chills) outcome was unknown and MUSCULOSKELETAL STIFFNESS (neck stiffness/neck spasm) had not resolved.            No concomitant medications were provided by the reporter.  It was reported that after 2 and half to 3 months later (may-2021) patient started noticing numbeness of right hand, twingling of fingers and stiffness of neck especially while sleeping, un esay when hand is in rest, unable to see the mirror.  This case was linked to MOD-2021-241131 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Added patient height & weight,,batch/ lot number of the first dose, allergic condition, updated the vaccine facility information, treatment for neck spasm,updated symptoms include chills, flushing, feeling hot, rash & the event out come for neck spasm as ongoing.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Bedridden, Bone pain, Headache
Clinical narrative: Couldn't get out of bed the second day; Tenderness in kidney; Stiffness and tension in neck and collar/Stiffness in shoulder; Swelling of joints; Deep bone pains; Stiffness in joints; Joint pain; Severe headache; Woke up very weak; Couldn't pick myself up; Hurt everywhere; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021.    This spontaneous case was reported by an other health care professional and describes the occurrence of ASTHENIA (Woke up very weak), HYPOKINESIA (Couldn't pick myself up), PAIN (Hurt everywhere), BEDRIDDEN (Couldn't get out of bed the second day) and RENAL PAIN (Tenderness in kidney) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Surgery (cervical spine surgery.), Surgery (dire placement), Surgery (Orthopedic surgery on back and nose.) and Renal surgery (renal surgery).   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Feb-2021, the patient experienced ASTHENIA (Woke up very weak), HYPOKINESIA (Couldn't pick myself up), PAIN (Hurt everywhere), RENAL PAIN (Tenderness in kidney), MUSCULOSKELETAL STIFFNESS (Stiffness and tension in neck and collar/Stiffness in shoulder), JOINT SWELLING (Swelling of joints), BONE PAIN (Deep bone pains), JOINT STIFFNESS (Stiffness in joints), ARTHRALGIA (Joint pain) and HEADACHE (Severe headache). On 15-Feb-2021, the patient experienced BEDRIDDEN (Couldn't get out of bed the second day). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, ASTHENIA (Woke up very weak), HYPOKINESIA (Couldn't pick myself up), PAIN (Hurt everywhere), BEDRIDDEN (Couldn't get out of bed the second day), RENAL PAIN (Tenderness in kidney), MUSCULOSKELETAL STIFFNESS (Stiffness and tension in neck and collar/Stiffness in shoulder), JOINT SWELLING (Swelling of joints), BONE PAIN (Deep bone pains), JOINT STIFFNESS (Stiffness in joints), ARTHRALGIA (Joint pain) and HEADACHE (Severe headache) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication use was not provided by reporter. Along with other treatment medications 'Hot bath for stiffness' was also reported by reporter.